You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

decitabine

Showing 51 - 75 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent, Platinum-resistant Ovarian Cancer Trial in Milan (Decitabine, Carboplatin, Pegylated Liposomal Doxorubicin)

Recruiting
  • Recurrent, Platinum-resistant Ovarian Cancer
  • Decitabine
  • +4 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021

Relapsed/Refractory AML Trial in Suzhou (Selinexor, Homoharringtonine, Cytarabine)

Not yet recruiting
  • Relapsed/Refractory AML
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 28, 2023

Engraft Failure, Relapse, GVHD Trial (decitabine, Acetylcysteine, Semustine)

Not yet recruiting
  • Engraft Failure
  • +2 more
  • decitabine
  • +8 more
  • (no location specified)
Jun 22, 2021

Acute Myeloid Leukemia (AML), Cancer Trial in United States (venetoclax, azacytidine, decitabine)

Completed
  • Acute Myeloid Leukemia (AML)
  • Cancer
  • Tempe, Arizona
  • +15 more
Jun 10, 2022

Acute Myeloid Leukemia, Blasts 30 Percent or Less of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2021

Response Rate Trial in Shanghai (Decitabine)

Completed
  • Response Rate
  • Decitabine
  • Shanghai, Shanghai, China
    Blood & Marrow Transplantation Center, RuiJin Hospital
May 19, 2021

Myelodysplastic Syndrome (MDS) Trial in United States (MBG453, Azacitidine, Decitabine)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Chandler, Arizona
  • +22 more
Dec 5, 2022

Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

Not yet recruiting
  • Leukemia, Acute Myeloid (AML)
  • (no location specified)
Oct 16, 2022

Acute Myeloid Leukemia, Complex Karyotype Trial in Hong Kong (Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Complex Karyotype
  • Decitabine
  • Hong Kong, Hong Kong
    The University of Hong Kong
Apr 26, 2021

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

AML/MDS Trial in Worldwide (Decitabine, Midostaurin)

Active, not recruiting
  • AML/MDS
  • Antwerpen, Belgium
  • +36 more
Dec 29, 2021

Diffuse Large B Cell Lymphoma Trial (Rituximab, Cyclophosphamide, Doxorubicin)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Apr 24, 2022

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Decitabine
  • Arsenic Trioxide
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

Acute Myeloid Leukemia, MDS Trial in Worldwide (Bemcentinib, Cytarabine, Decitabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Iowa City, Iowa
  • +11 more
Mar 1, 2022

Acute Myeloid Leukemia, MDS Trial in Philadelphia (Decitabine, Digoxin)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Philadelphia, Pennsylvania
  • +1 more
Feb 22, 2021

Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma in the Soft Tissue

Withdrawn
  • Castration Levels of Testosterone
  • +8 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 31, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Philadelphia, Houston (Decitabine,

Completed
  • Acute Myeloid Leukemia
  • +2 more
  • Decitabine
  • +2 more
  • Philadelphia, Pennsylvania
  • +1 more
May 18, 2021

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden Trial in Beijing (Chidamide, Decitabine, Chidamide and

Unknown status
  • Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinese PLA General Hospital
Dec 3, 2020

MDS Trial in France (Decitabine, HYDROXYUREA)

Completed
  • MDS
  • Saint-Denis, La Réunion, France
  • +44 more
Nov 17, 2021

Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Brewer, Maine
  • +8 more
Jun 18, 2021

Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))

Completed
  • Acute Myelogenous Leukemia
  • Decitabine
  • +4 more
  • Los Angeles, California
  • +32 more
Jun 22, 2022

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020

Leukemia Trial in Houston (Dasatinib, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 29, 2020

Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

Terminated
  • Advanced Malignancies
  • Baltimore, Maryland
  • +13 more
Sep 20, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Alvocidib Hydrochloride, Decitabine,

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Alvocidib Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2020